Head of Global Marketing & Launch Lead, Dermatology

Avalo Therapeutics; Chesterbrook (PA); On-site; USD 140,000 - 180,000; Full time

Job summary

Avalo Therapeutics in Chesterbrook is seeking a Head of Global Marketing & Launch Lead for its first product launch. The role demands strategic leadership in developing launch readiness plans and shaping brand strategies for abdakibart, focusing on Hidradenitis Suppurativa (HS).

The ideal candidate will have experience leading major product launches in the biotechnology sector and possess a deep understanding of commercial strategies. A strong foundation in dermatology or immunology is preferred. Join us in making an impact on patients' lives with innovative therapies.

Qualifications

• 12+ years in biotechnology, pharmaceutical, or healthcare industry.
• 5+ years in launch planning or commercial operations.
• Experience in dermatology and/or immunology preferred.

Responsibilities

• Lead overall commercial strategy for abdakibart in Hidradenitis Suppurativa.
• Develop launch readiness plans and brand strategies.
• Generate insights from various healthcare stakeholders.

Skills

Commercial strategy development

Brand leadership

Market assessment

Customer insights generation

Cross-functional collaboration

Education

Bachelor's degree

Advanced degree (MBA, MPH, PharmD, MS, or PhD)

Job description

Head of Global Marketing & Launch Lead, Dermatology

Chesterbrook, PA

At Avalo (ahh-vah'-low), we are 100% focused on developing treatments for immune-mediated inflammatory diseases with large unmet needs that affect millions worldwide. Our strategy is to develop medicines that target the IL-1β pathway, which is a central driver of the inflammatory process.

We share a commitment to teamwork, passion for science, and dedication to patients suffering from acute and chronic inflammatory disorders. Our collective expertise in discovery, development, and regulatory approvals is evidenced in our strong individual track records of advancing multiple therapeutic programs to successful commercialization.

Position Summary

This individual will serve as the commercial architect for Avalo's first potential product launch. The successful candidate will be responsible for developing and executing global and U.S. launch readiness plans, shaping brand strategy, generating deep customer insights, building commercial capabilities, and partnering cross-functionally to maximize the value of the HS franchise.

This highly visible leadership role requires a strategic thinker who can operate effectively in a fast-paced biotechnology environment while balancing long-term commercial vision with hands‑on execution. The individual will work closely with Clinical Development, Medical Affairs, Market Access, Regulatory Affairs, Investor Relations, Business Development, and external partners to position Avalo for a successful commercialization and growth trajectory.

Essential Duties and Responsibilities

Commercial Strategy & Brand Leadership

• Advance and lead the overall commercial strategy for abdakibart, Avalo’s lead drug candidate, in Hidradenitis Suppurativa (HS).
• Build the brand vision, positioning, messaging, value proposition, and lifecycle strategy
• Direct market assessment, forecasting, competitive intelligence, and commercial planning activities.
• Translate clinical and scientific data into differentiated customer‑focused strategies.
• Identify market opportunities, risks, and competitive dynamics to inform business decisions.
• Serve as the commercial lead on cross‑functional program teams.
• Manage external agency partners.
• Build and execute comprehensive cross‑functional launch readiness plans.
• Establish launch milestones, KPIs, governance structures, and performance tracking mechanisms.
• Lead pre‑launch customer engagement and market shaping initiatives.
• Ensure organizational readiness across marketing, sales, market access, patient services, and operations.
• Develop launch scenarios and contingency plans to support evolving clinical and regulatory timelines.

Customer Insights & Market Development

• Generate actionable insights from healthcare providers, patients, payers, advocacy groups, and key opinion leaders.
• Develop customer segmentation and targeting strategies.
• Establish strong relationships with external experts, advocacy organizations and HS stakeholders.

Market Access & Value Strategy

• Partner closely with Market Access to develop payer, reimbursement, and value communication strategies.
• Support pricing, contracting, and access planning efforts.
• Ensure commercial strategies are aligned with payer expectations and patient access objectives.

Cross‑Functional Leadership

• Collaborate closely with Clinical Development and operations, HEOR, Medical Affairs, Regulatory Affairs, , Manufacturing, and Supply Chain to ensure commercial perspectives are integrated throughout development.
• Partner with Medical Affairs to optimize scientific communication plans and publication strategies.
• Support investor and board communications regarding the commercial opportunity for abdakibart in HS and launch readiness plans Represent commercial perspectives in governance and strategic planning discussion

Required Education and Experience

• Bachelor's degree required; advanced degree (MBA, MPH, PharmD, MS, or PhD) preferred.
• 12+ years of biotechnology, pharmaceutical, or healthcare industry experience.
• 5+ years leading launch planning, launch excellence, commercial operations, new product planning, or strategic program management.
• Demonstrated success leading at least one major pharmaceutical or biotechnology product launch.
• Experience coordinating complex, cross‑functional initiatives in a matrixed environment.
• Experience in dermatology and/or immunology/inflammation specialty products, preferred.

Preferred Qualifications

• Experience launching biologics or specialty therapies.
• Understanding of HS, dermatology, immunology, or inflammatory disease markets.
• Experience within emerging biotechnology companies and first‑launch organizations.
• Familiarity with global launch planning and commercialization frameworks.

About Avalo Therapeutics

Avalo Therapeutics is a clinical stage biotechnology company fully dedicated to developing therapeutics targeting the IL-1β pathway for immune‑mediated inflammatory diseases. Our lead asset, abdakibart, is an anti‑IL‑1β monoclonal antibody (mAb). Positive topline data was recently reported for abdakibart in a Phase 2 clinical trial in hidradenitis suppurativa (HS). In addition to HS, we’re exploring additional opportunities to make an impact in prevalent indications that have significant remaining unmet needs. We are also advancing AVTX‑010, a long‑acting next‑generation anti‑IL‑1β mAb designed to extend dosing intervals and build upon the differentiated profile established by abdakibart. For more information about Avalo, please visit www.avalotx.com.